Tesamorelin 10mg

About Tesamorelin

What is Tesamorelin?

Tesamorelin (CAS 218949-48-5) is a stabilised analogue of growth-hormone-releasing hormone (GHRH). It acts at the GHRH receptor, upstream of ghrelin-receptor secretagogues such as ipamorelin. A trans-3-hexenoyl group on the N-terminus improves stability versus native GHRH.

Werhner Lab supplies tesamorelin as lyophilised powder in 10 mg vials.

CAS: 218949-48-5. Molecular weight: ~5135.9 g/mol. Target: GHRH-R.

How Tesamorelin is studied in the literature

The literature treats tesamorelin as a GHRH-receptor tool for GH-axis and metabolic models. Background only; not a claim about individual effects.

GHRH-receptor and GH-cascade research

Used to study receptor activation, GH release, and downstream IGF-axis biochemistry in controlled models.

Metabolic and body-composition models

Also appears in work on visceral-adipose and metabolic signalling that starts from GHRH-style stimulation rather than GHS-R.

Within the class — how Tesamorelin differs

Tesamorelin is not a GHRP. Ipamorelin pushes the ghrelin receptor. Tesamorelin mimics hypothalamic GHRH. Labs pick it when the question is the GHRH receptor itself, or an upstream trigger of the GH axis.

Research areas

• GHRH-receptor pharmacology
• GH / IGF-axis cascade models
• Comparison of GHRH analogues versus GHS-R secretagogues
• Peptide-stability work on N-terminally modified GHRH

Specifications

CAS	218949-48-5
Molecular weight	~5135.9 g/mol
Receptor profile	GHRH-R agonist
Purity	≥ 97.5% (batch CoA)
Form	Lyophilised powder, sealed vial
Size	10 mg

Storage

Powder: −20°C long term; 2–8°C short term.

Reconstituted: 2–8°C; do not freeze unless the protocol requires it.

Quality

Batch CoA on request. Batch example: TM10-6127.

Important notice — Research Use Only

Tesamorelin is supplied by Werhner Lab for laboratory research only. Not a medicine or supplement. Not for human consumption.